Amedisys Inc
NASDAQ:AMED
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
89.45
98.45
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Amedisys Inc
Amedisys Inc
Total Equity
Amedisys Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Amedisys Inc
NASDAQ:AMED
|
Total Equity
$1.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
|
|
DaVita Inc
NYSE:DVA
|
Total Equity
$386.7m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-23%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Equity
$6.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
CVS Health Corp
NYSE:CVS
|
Total Equity
$74.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Cigna Corp
NYSE:CI
|
Total Equity
$42.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
14%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Equity
$8.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
Amedisys Inc
Glance View
Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 21,000 full-time employees. The firm operates through four segments: Home Health, Hospice, Personal Care and high acuity care. The Home Health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with important personal tasks. The Hospice segment provides palliative care and comfort to terminally ill patients and their families. The Personal Care segment provides patients with assistance with the essential activities of daily living. Its high acuity care segment delivers the essential elements of inpatient hospital and skilled nursing facility (SNF) care to patients in their homes. The firm owns and operates approximately 530 care centers in 38 states.
See Also
What is Amedisys Inc's Total Equity?
Total Equity
1.1B
USD
Based on the financial report for Sep 30, 2024, Amedisys Inc's Total Equity amounts to 1.1B USD.
What is Amedisys Inc's Total Equity growth rate?
Total Equity CAGR 10Y
12%
Over the last year, the Total Equity growth was 10%. The average annual Total Equity growth rates for Amedisys Inc have been 8% over the past three years , 14% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
